Reported Mar 14, 2018 · Terminated
Lynparza (olaparib) capsules 50 mg, 112 count bottles, Rx only, Manufactured for: Astra Zeneca Pharmaceuticals LP…
AstraZeneca Pharmaceuticals LP
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: AstraZeneca Pharmaceuticals LP · 1800 Concord Pike · Wilmington, DE · 19897-0001
Is this the product you have?
Lynparza (olaparib) capsules 50 mg112 count bottlesRx only
- Manufactured forAstra Zeneca Pharmaceuticals LP Wilmington
- DE 19850 byPatheon Pharmaceuticals, Inc. Cincinnati OH 45237 Product of Switzerland NDC 0310-0657-58
- Lot codes and dates
HN040602/2018JH034103/2018JH034203/2018JH014703/2018JC039104/2018JK014704/2018JL018404/2018JC040205/2018
- Amount recalled
- 18056 bottles
Where it was sold
- Nationwide
Why it was recalled
Failed Impurities/Degradation Specifications; elevated levels of quality attribute Form L (polymorph).
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new AstraZeneca Pharmaceuticals LP recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.